KRASG12C IN-17
KRASG12C IN-17 is an orally active covalent KRASG12C inhibitor, showing strong inhibitory activity in KRASG12C-mutant cancer cells (NCI-H23 IC50 = 0.7 nM; NCI-H358 IC50 = 0.5 nM) . KRASG12C IN-17 covalently and irreversibly binds to KRASG12C with > 96% modification efficiency in both GDP-bound and GMPPNP-bound conformations. KRASG12C IN-17 can be used for studies of KRAS-driven cancers, including colorectal cancer[1].
Product Specifications
CAS Number
2966924-23-0
UNSPSC
12352005
Target
Ras
Related Pathways
GPCR/G Protein; MAPK/ERK Pathway
Field of Research
Cancer
Smiles
N#CC[C@@H]1N(C(C(F)=C)=O)CCN(C2=C3C=C(F)C(C4=C5C(C#C)=CC=CC5=CC=C4)=C(F)C3=NC(OCC67CCCN6CCC7)=N2)C1
Molecular Formula
C37H33F3N6O2
Molecular Weight
650.69
References & Citations
[1]Gao K, et al. Structure-based design and synthesis of novel highly potent and selective KRASG12C inhibitors. Eur J Med Chem. 2026;302 (Pt 2) :118321. doi:10.1016/j.ejmech.2025.118321
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
K-Ras
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Histone H3 (acetyl K27) Mouse Monoclonal Antibody [A6D7]](https://cdn.genprice.uk/products/992/68dd1c8a061270361ea80fb9/imageurl/ha600047.webp)
HA600047 100 µL
Histone H3 (acetyl K27) Mouse Monoclonal Antibody [A6D7]
Sign In for Pricing
View Details 
